Abstract
In eukaryotic cells, the degradation of messenger RNA (mRNA) is an essential determinant in the regulation of gene expression. Indeed, the need to rapidly interrupt cellular responses to various stimuli (growth or developmental) upon the disappearance of the inducing signal necessitates the tight regulation of the degradation process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aguet M, Dembic Z, Merlin G (1988) Molecular cloning and expression of the human interferon Y receptor. Cell 55: 273–280
Baglioni C, Minks MA, Maroney PA (1978) Interferon action may be mediated by activation of a nuclease by pppA2´p5A2´p5´A. Nature 273: 784–787
Bayard B, Bisbal C, Silhol M, Cnockaert J, Huez G, Lebleu B (1984) Increased stability and antiviral activity of 2´-0-phosphoglyceryl derivatives of (2´–5´)oligo(adenylate). Eur J Biochem 142: 291–298
Bayard B, Bette-Bobillo P, Aliau S (1994) Affinity purification and characterization of (2´5´)oligo(adanylate)-dependent RNase from mouse spleen. Eur J Biochem 223: 403–410
Benech P, Mory Y, Revel M, Chebath J (1985) Structure of two forms of the interferon-induced (2´–5´) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J 4: 2249–2256
Bisbal C, Silhol M, Lemaitre M, Bayard B, Salehzada T, Lebleu B (1987) 5´-modified agonist and antagonist (2´-5´)(A)n analogues: synthesis and biological activity. Biochemistry 26:5172–5178
Bisbal C, Salehzada T, Lebleu B, Bayard B (1989) Characterization of two murine (2´-5´)(A)n-dependent endonucleases of different molecular mass. Eur J Biochem 179: 595–602
Bisbal C, Martinand C, Silhol M, Lebleu B, Salehzada T (1995) Cloning and characterization of a RNase L inhibitor. J Biol Chem 270: 13308–13317
Brown GE, Lebleu B, Kawakita M, Shaila S, Sen GC, Lengyel P (1976) Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence on double-stranded RNA. Biochem Biophys Res Commun 69: 114–122
Cayley P, Knight M, Kerr IM (1982) Virus-mediated inhibition of the ppp(A2´p)nA system and its prevention by interferon. Biochem Biophys Res Commun 104: 376–382
Chebath J, Benech P, Hovanessian AG, Galabru J, Revel M (1987a) Four different forms of interferon-induced 2´,5´ oligo(A)synthetase identified by immunoblotting in human cells. J Biol Chem 262: 3852–3857
Chebath J, Benech P, Revel M, Vigneron M (1987b) Constitutive expression of (2´-5´)oligo A synthetase confers resistance to Picornavirus infection. Nature 330: 587–588
Clemens MJ, Williams BRG (1978) Inhibition of cell-free protein synthesis by pppA2´p5´A2´p5´A a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 13: 565–572
Decker T, Lew D, Mirkovitch J, Darnell JE jr (1991) Cytoplasmic activation of GAF, an IFN-y-regulated DNA binding factor. EMBO J 10: 927–932
Dong B, Silverman R (1995) 2-5A-dependent RNase molecules dimerize during activation by 2–5A. J Biol Chem 270:4133–4137
Dong B, Xu L, Hassel B, Lee X, Torrence P, Silverman R (1994) Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J Biol Chem 269: 14153–14158
Einat M, Resnitzki D, Kimchi A (1985) Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 313: 597–600
Eppstein DA, Marsh VY, Schryver BB, Larsem MA, Barnett JW, Verheyden JPH, Prisbe E (1982) Analogs of (A2´p)nA. Correlation of structure of analogs of ppp(A2´p)2A and (A2´p)2A with stability and biological activity. J Biol Chem 257: 13390–13397
Floyd-Smith G, Slattery E, Lengyel P (1981) Interferon action: RNA cleavage pattern of a (2´–5´)oligoadenylate-dependent endonuclease. Science 212: 1030–1032
Floyd-Smith G, Yoshie O, Lengyel P (1982) Covalent linkage of (2´–5´)pppApApA(32P)pCp to (2´–5´)(A)n-dependent ribonuclease in cell extracts by ultraviolet irradiation. J Biol Chem 257: 8584—8587
Fu XY, Schindler C, Improta T, Aebersold R, Darnell JE jr (1992) The proteins of ISGF-3, the interferon α-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 89: 7840–7843
Gray PW, Leung DW, Pennica D, Yelverton E, Najaria P, Simonsen CC, Derynnck D, Sherwood PJ, Wallace DM, Berger SL, Levinson AD, Goeddel DV (1982) Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295: 503–508
Gribaudo G, Lembo D, Cavallo G, Landolfo S, Lengyel P (1991) Interferon action: binding of viral RNA to the 40-kilodalton 2´-5´-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol 65: 1748–1757
Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T (1989) Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729–739
Hassel B, Zhou A, Sotomayor C, Maran A, Silverman R (1993) A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon EMBO J 12: 3297–3304
Hovanessian AG, Kerr IM (1978) Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells. Eur J Biochem 84: 149–159
Hovanessian AG, Brown RE, Kerr IM (1977) Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature 268: 537–540
Hovanessian AG, Laurent AG, Chebath J, Galabru J, Robert N, Svab J (1987) Identification of 69 kd and 100 kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies. EMBO J 6: 1273–1280
Hovanessian G, Svab J, Marié I, Robert N, Chamaret S, Laurent AG (1988) Characterization of 69-100-kDa forms of 2-5A synthetase from interferon-treated human cells. J Biol Chem 263: 4945–4949
Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond Biol Sci 147: 258–267
Jackson RJ (1993) Cytoplasmic regulation of mRNA function: the importance of the 3´ untranslated region. Cell 74: 9–14
Jaramillo M, Abraham N, Bell JC (1995) The interferon system: a review with emphasis on the role of PKR in growth control. Cancer Invest 13 (3): 327–338
Johnston MI, Head WG (1987) Characterization of a 2´-phosphodiesterase from bovine spleen. J Biol Chem 262: 8377–8382
Jonak GJ, Knight E jr (1984) Selective reduction of c-myc mRNA in Daudi cells by human ß interferon. Proc Natl Acad Sci USA 81: 1747–1750
Kerr IM, Brown RE (1978) pppA2´p5´A2´p5´A an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci USA 75:256–260
Kerr IM, Brown RE, Ball LA (1974a) Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment. Nature 250: 57–59
Kerr IM, Friedman RE, Brown RE, Ball A, Brown JC (1974b) Inhibition of protein synthesis in cell-free systems from interferon-treated infected cells: furter characterization and effect of formylmethionyl-t-RNA. J Virol 13: 9–21
Kerr IM, Brown RE, Clemens MJ, Gilbert CS (1976) Interferon-mediated inhibition of cell-free-protein synthesis in response to double-stranded RNA. Eur J Biochem 69: 551–561
Knight M, Cayley PJ, Silverman RH, Wreschner DH, Gilbert CS, Brown RE, Kerr IM (1980) Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature 288: 189–192
Kumar A, Haque J, Lacoste J, Hiscott J, Williams BRG (1994) Double-stranded RNA-dependent protein kinase activates transcription factor NF-кB by phosphorylating IкB. Proc Natl Acad Sci USA 91: 6288–6292
Lin SL, Garber EA, Wang E, Galiguiri LA, Schellekens H, Goldberg AR, Tamm I (1983) Reduced synthesis of pp60 Src and expression of the transformation-related phenotypes in interferon-treated Rous sarcoma virus-transformed rat cells. Mol Cell Biol 3: 1656–1664
Maitra RK, Li G, Xiao W, Dong B, Torrence P, Silverman R (1995) Catalytic cleavage of an RNA target by 2–5A antisense and RNase L. J Biol Chem 270: 15071–15075
Maran A, Maitra R, Kumar A, Dong B, Xia W, Li G, William BRG, Torrence P, Silverman R (1994) Blockage of NF-кB signaling by selective ablation of an mRNA target by 2–5A antisens chimeras. Science 265: 789–792
Marié I, Hovanessian AG (1992) The 69-kDa 2–5A synthetase is composed of two homologous and adjacent functional domains. J Biol Chem 267: 9933–9939
Martinand C, Bisbal C, Silhol M, Lebleu B. Salehzada T (1994) Constitutive expression of sense and antisense constructions of RLI in human cells modify the RNase L pathway. J Interferon Res 14 (Suppl 1): 102
Martinand C, Salehzada T, Silhol M, Lebleu B, Bisbal C (1995) The RNase L inhibitor (RLI) is induced by poly(I)poly(C). J Interferon Res 15 (Suppl 1): 148
Merlin G, Chebath J, Benech P, Metz, Revel M (1983) Molecular cloning and sequence of partial cDNA for interferon-induced (2´5´)oligo(A)synthetase mRNA from human cells. Proc Natl Acad Sci USA 80: 4904–4908
Meurs E, Hovanessian AG (1988) α-Interferon inhibits the expression of heavy µ messager RNA in Daudi cells. EMBO J 7:1689–1696
Meurs E, Chong K, Galabru J, Thomas N, Kerr I, Williams BRG, Hovanessian AG (1990) Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62: 379–390
Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T (1988) Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-ß gene regulatory elements. Cell 54: 903–913
Mory Y, Vaks B, Chebath J (1989) Production of two human 2´-5´-oligoadenylate synthetase enzymes in Escherichia coli . J Interferon Res 9: 295–304
Mundschau L, Faller D (1995) Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. J Biol Chem 270: 3100–3106
Nagata S, Mantei N, Weissmann C (1980) The structure of one of the eight or more chromosomal genes for human interferon α. Nature 28: 401–408
Naylor SL, Sakagushi AY, Shows TB, Law ML, Goeddel DV, Gray PW (1983) Human immune interferon gene is located on chromosome 12. J Exp Med 157: 1020–1027
Nilsen TW, Maroney PA, Baglioni C (1981) Double-stranded RNA causes synthesis of 2´-5´-oligo(A) and degradation of messenger RNA in interferon-treated cells. J Biol Chem 256: 7806–7811
Owerbach D, Rutter WJ, Shows TB, Gray P, Goeddel DV, Lawn RM (1981) Leucocyte and fibroblast interferon genes are located on human chromosome 9. Proc Natl Acad Sci USA 78: 3123–3127
Paucker K, Can tell K, Henle W (1962) Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. Virology 17: 324–334
Pellegrini S, Schindler C (1993) Early events in signalling by interferons. Trends Biochem Sci 18: 338–342
Proud CG (1995) PKR: a new name and new roles TIBS 20: 241–246
Ratner L, Wiegand RC, Farrell PJ, Sen GC, Cabrer B, Lengyel P (1978) Interferon, double stranded RNA and RNA degradation. Fractionation of the endonuclease TNT system into two macromolecular components: role of a small molecule in nuclease activation. Biochem Biophys Res Commun 81: 947–954
Rosa F, Cochet M, Fellous M (1986) Interferon and major histocompatibility complex genes: a model to analyse eucaryotic gene regulation ? Interferon 7:47–87, Harcourt Brace Jovanovich, Academic Press, London
Sach B (1993) Messenger RNA degradation in eucaryotes. Cell 74: 413–421
Salehzada T, Silhol M, Lebleu B, Bisbal C (1991a) Polyclonal antibodies against RNase L. Subcellular localization of this enzyme in mouse cells. J Biol Chem 266: 5808–5813
Salehzada T, Silhol M, Lebleu B, Bisbal C (1991b) Regeneration of enzyme activity after Western blot: activation of RNase L by 2–5A on filter. Importance for its detection. Anal Biochem 196: 410–414
Salehzada T, Silhol M, Steff AM, Lebleu B, Bisbal C (1993) 2´,5´-oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits. J Biol Chem 268:7733–7740
Schindler C, Darnell JE (1995) Transcriptional responses to polypeptide ligands: the Jak-STAT pathway. Annu Rev Biochem 64: 621–651
Schindler C, Fu XY, Improta T, Aebersold R, Darnell JE Jr (1992) Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon α. Proc Natl Acad Sci USA 89: 7836–7839
Schmidt A, Zilberstein A, Shulman L, Federman P, Berissi H, Revel M (1978) Interferon action: isolation of nuclease F, a translation inhibitor activated by interferon-induced (2´-5´)oligo-isoadenylate. Febs Lett 95: 257–264
Schmidt A, Chernajovsky Y, Shulman L, Federman P, Berissi H, Revel M (1979) An interferon-induced phosphodiesterase degrading (2´,5´) oligoisoadenylate and C-C-A terminus of tRNA. Proc Natl Acad Sci USA 76: 4788–4792
Sen GC, Lengyel P (1992) The interferon system, a bird’s eye view of its biochemistry. J Biol Chem 267: 5017–5020
Sen GC, Lebleu B, Brown GE, Kawakita M, Slattery E, Lengyel P (1976) Interferon, double-stranded RNA and mRNA degradation. Nature 264: 370–373
Silverman RH (1985) Functional analysis of 2–5A-dependent RNase and 2–5A using 2´5´ oligo-adenylate-cellulose. Anal Biochem 144: 450–460
Silverman R, Skehel J, James T, Wreschner D, Kerr IM (1984) rRNA cleavage as an index of ppp(A2´p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J Virol 46:1051–1055
Slattery E, Ghosh N, Samanta H, Lengyel P (1979) Interferon, double-stranded RNA and RNA degradation: activation of an endonuclease by (2´-5´)An. Proc Natl Acad Sci USA 76: 4778–4782
Sperling J, Chebath J, Arad-Dann H, Offen D, Spann P, Lehrer R, Goldblatt D, Jolles B, Sperling R (1991) Possible involvement of (2´–5´)oligoadenylate synthetase activity in pre-mRNA splicing. Proc Natl Acad Sci USA 88: 10377–10381
Staeheli P, Haller O, Boll W, Lindenmann J, Weissman C (1986) Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44: 147–158
Taniguchi T, Mantei N, Swarztein M, Nagata S, Muramatsu M, Weissmann C (1980) Human leukocyte and fibroblast interferons are structurally related. Nature 285: 547–549
Tavernier J, Derynck R, Fiers W (1981) Evidence for a unique human fibroblast interferon (IFN-ß l) chromosomal gene, devoid of intervening sequences. Nucl Acids Res 9: 461–471
Torrence PF, Xiao W, Li G, Khamnei S (1994) Development of 2´,5´-oligonucleotides as potential therapeutic agents. Curr Med Chem 1: 176–191
Trent YM, Olson S, Lawr RM (1982) Chromosomal localization of human leucocyte, fibroblaste and immune interferon genes by means of in situ hybridization. Proc Natl Acad Sci USA 79: 7809–7813
Uzé G, Lutfalla G, Gresser I (1990) Genetic transfer of functional human interferon α receptor into mouse cells: cloning and expression of its cDNA. Cell 60: 225–234
Uzé G, Lutfalla G, Mogensen K (1995) α and ß interferons and their receptor and their friends and relations. J Interferon Res 15:3–26
Williams BRG (1991) Transcriptional regulation of interferon-stimulated genes. Eur J Biochem 200: 1–11
Williams BRG, Saunders ME, Williard HF (1986) Interferon-regulated human 2´-5´ synthetase gene maps to chromosome 12. Somat Cell Mol Genet 12: 403–408
Wreschner DH, McCauley JW, Skehel JJ, Kerr IM (1981) Interferon action-sequence specificity of the ppp(A2´p)nA-dependent ribonuclease. Nature 289: 414–417
Zhou A, Hassel B, Silverman R (1993) Expression cloning of 2-5A-dependent RNase: a uniquely regulated mediator of interferon action. Cell 72: 753–765
Zilberstein A, Kimchi A, Schmidt A, Revel M (1978) Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proc Natl Acad Sci USA 75: 4734–4738
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bisbal, C. (1997). RNase L: Effector Nuclease of an Activatable RNA Degradation System in Mammals. In: Jeanteur, P. (eds) Cytoplasmic fate of messenger RNA. Progress in Molecular and Subcellular Biology, vol 18. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60471-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-60471-3_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64420-7
Online ISBN: 978-3-642-60471-3
eBook Packages: Springer Book Archive